Ovid Therapeutics Inc. (OVID)

Ovid Therapeutics Revenue

Ovid Therapeutics had revenue of $7.12M in the twelve months ending March 31, 2026, up 1,199.64% year-over-year. In the year 2025, Ovid Therapeutics had annual revenue of $7.25M with 1,181.27% growth.

• Revenue (ttm): $7.12M
• Revenue Growth: +1,199.64%
• P/S Ratio: 65.25
• Revenue / Employee: $309,652
• Employees: 23
• Market Cap: 476.87M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	7.25M	6.69M	1,181.27%
Dec 31, 2024	566.00K	174.00K	44.39%
Dec 31, 2023	392.00K	-1.11M	-73.91%
Dec 31, 2022	1.50M	-206.88M	-99.28%
Dec 31, 2021	208.38M	195.77M	1,551.58%
Dec 31, 2020	12.62M	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	-	-	-
Dec 31, 2016	-	-	-
Dec 31, 2015	-	-	-

Data Source: Fiscal.ai Last updated: May 12, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 25, 2026

Data Sources Report a data error